Free AutoResponder Trial
Are You Looking For a Free AutoResponder? We would like to invite you try TrafficWave, absolutely free, for the next 30 days.
What do you get during your free autoresponder trial? Full access to a powerful email marketing system that you can use to generate more leads for your business, follow up with prospects, and close more sales.
You will be able to set up and manage unlimited campaigns.
Each campaign can hold an unlimited number of subscribers.
Even if you’ve never built an email marketing list, you can get started quickly with our 30 Minute List Building Challenge during your free autoresponder trial period. Even if you cancel before your 30 day free trial, any leads you generate are yours to keep!
Why Do We Offer a Free Autoresponder Trial?
We believe every business should be using email marketing. We also know that some people may feel intimidate if they have never actually used email marketing before. A free trial makes it easy for you to kick the tires and experience the power of email marketing for yourself without risking any money. We won’t even ask you for payment information until you are ready to upgrade.
When you decide to upgrade, you will pay a flat monthly rate of just $17.95 per month. That’s about 60 cents per day! When you use these tools to their potential, your business will be able to generate sales well beyond that price!
We invite you to register for your Free 30 Day Trial, today. Our support team will be here to help you get the right start.
Still not sure? Check out these resources for even more information:
Email Marketing Success Stories
Why I Believe In Online Lead Generation
You can check out our video training series here: TrafficWave Video Training Series
We look forward to helping you grow your business. Feel free to ask any questions you may have.
Find TrafficWave On Social Media
Request our free report to receive more details on how you can use email marketing to build your lists and grow your business.
Your information will be kept private.
All Comments
Write a Comment